|
Hedge fund Citadel has made a £305 million bet against pharmaceuticals firm GSK PLC, the biggest short position against the company in more than a decade, according to the Financial Times. Billionaire Ken Griffin’s hedge fund disclosed that it had entered the net short position on Tuesday, with the bet worth 0.51% of the company‘s stock, according to data from the Financial Conduct Authority compiled by provider Breakout Point. The last time any firm disclosed a bet against the FTSE 100 pharmaceutical group was in 2013, according to the FCA disclosures, the FT reported. GSK’s shares have risen 11% in the last month, as the drugmaker raised its long-term sales forecast and embarked on a rare £2 billion stock buyback earlier this month. GSK reported better than expected earnings on strong sales of HIV and cancer drugs. But the stock has lagged rival pharmaceutical companies, as the drugmaker has failed to excite investors about its pipeline of new medicines and vaccines, which it needs to replace its HIV drugs when they face a patent cliff later in the decade, the FT added. Shares in GSK closed 0.8% lower at 1,432.50 pence each in London on Friday. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
